CLL (Chronic Lymphocytic Leukemia)
Oncology·MeSH: Myeloproliferative Disorders
Prevalence
20.0 / 100K
Incidence
4.7 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target CLL (Chronic Lymphocytic Leukemia)?
There are 1 clinical trial targeting CLL (Chronic Lymphocytic Leukemia) tracked by BioSniper.
What is the prevalence of CLL (Chronic Lymphocytic Leukemia)?
The estimated prevalence of CLL (Chronic Lymphocytic Leukemia) is approximately 20.0 per 100,000 population.
Deep-dive into CLL (Chronic Lymphocytic Leukemia)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis